Regulation - Anti-virals, Germany

Filter

Current filters:

Anti-viralsGermany

Popular Filters

Germany’s IQWiG views Xofigo, Kadcyla and Eviplera

03-04-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products, the…

Anti-viralsBayerEvipleraGermanyGilead SciencesKadcylaNorthern EuropeOncologyPharmaceuticalPricingRegulationRocheXofigo

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top